Foster Wheeler on Wednesday announced its acquisition of Yonkers Industries, a 30-year-old, US-based company that specializes in the management of construction and commissioning of pharmaceutical and biotech facilities.
Yonkers also has capabilities to manage the full EPCm (engineering, procurement and construction management) of such facilities, according to Foster Wheeler officials.
With offices in California, North Carolina and Puerto Rico, Yonkers Industries has approximately 200 professionals.
Through its participation in a project-services partnership called Modular Partners, Yonkers also has the ability to provide modular project delivery services on a worldwide basis.
The acquisition of Yonkers Industries gives our pharmaceutical business a construction management capability in North America, said Kent Masters, CEO of Foster Wheeler. Yonkers has a global reputation for excellence in contract execution, and the addition of this construction management capability immediately strengthens our value proposition to pharmaceutical and biotech clients.
Foster Wheeler Biokinetics, our US-based pharmaceutical unit, will experience the most immediate benefit from this acquisition as the client portfolios and geographic coverage of the two companies fit together quite effectively," Masters continued.
"We believe that the project and construction management skills of Yonkers are a perfect complement to the biotech engineering expertise of Biokinetics.